Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on October 10, 202310/10/23
Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced Data Analytics
Posted on August 21, 20238/21/23
Maximizing Potential: Essential Steps for Successful Commercialization of Cell and Gene Therapies
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on June 13, 20236/13/23
Unlocking Success: Exploring Critical Factors for Launching Orphan Drugs
Posted on August 31, 20228/31/22
Single-Cell Multiomics: Opportunities, Challenges, and the Evolving Business Model
Posted on August 5, 20228/5/22
Three Keys to Value for Unlocking the Promise of Cell Therapies
Posted on June 21, 20226/21/22
Challenges of Scaling Up Cell Therapy to New Geographies
Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on March 23, 20223/23/22